Stay updated on Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.

Latest updates to the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedPage revision updated to v3.5.0; the previous revision v3.4.3 has been removed.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision updated to v3.4.3, replacing the previous revision v3.4.2.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page shows a minor revision update (Revision: v3.4.2 added; Revision: v3.4.1 removed) and no changes to study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this is a minor site maintenance update that does not affect study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check76 days agoChange DetectedMinor version update from v3.3.3 to v3.3.4 with no changes to study content, eligibility criteria, or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check97 days agoChange DetectedLocations section updated to include Pennsylvania as a site, replacing the prior 'Pennsylvania Locations' entry. The revision tag was updated from v3.3.2 to v3.3.3.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.